Co-Diagnostics, Inc. Common Stock

CODX trades at an RSI of 66.4 despite a microscopic market cap of $0.0B, signaling overbought conditions in a micro-cap medical diagnostics play. The 5.58% short interest is modest for a stock this illiquid, yet the absence of a meaningful P/E ratio suggests either minimal profitability or inconsistent earnings. Trading below its 52-week high provides minimal comfort given the RSI elevation—momentum-driven rallies in surgical instruments can reverse violently, especially in names with thin trading and limited institutional backing. This setup carries substantial execution risk typical of early-stage diagnostics companies, where clinical validation gaps and cash burn often trigger sharp drawdowns.